Opitz CA - Search Results

1

Tryptophan degradation in autoimmune diseases.

Opitz CA, Wick W, Steinman L, Platten M. Opitz CA, et al. Cell Mol Life Sci. 2007 Oct;64(19-20):2542-63. doi: 10.1007/s00018-007-7140-9. Cell Mol Life Sci. 2007. PMID: 17611712 Free PMC article. Review.

2

Pirfenidone inhibits TGF-beta expression in malignant glioma cells.

Burghardt I, Tritschler F, Opitz CA, Frank B, Weller M, Wick W. Burghardt I, et al. Among authors: opitz ca. Biochem Biophys Res Commun. 2007 Mar 9;354(2):542-7. doi: 10.1016/j.bbrc.2007.01.012. Epub 2007 Jan 10. Biochem Biophys Res Commun. 2007. PMID: 17234158

3

Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemia.

Platten M, Opitz CA, Kohlhof P, Hegenbart U, Ho AD, Wick W. Platten M, et al. Among authors: opitz ca. Neurology. 2007 Aug 14;69(7):707. doi: 10.1212/01.wnl.0000275547.39894.a6. Neurology. 2007. PMID: 17698797 No abstract available.

4

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Köppel A, Tolosa E, Hoberg M, Anderl J, Aicher WK, Weller M, Wick W, Platten M. Opitz CA, et al. Stem Cells. 2009 Apr;27(4):909-19. doi: 10.1002/stem.7. Stem Cells. 2009. PMID: 19353519

5

Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1).

Lanz TV, Opitz CA, Ho PP, Agrawal A, Lutz C, Weller M, Mellor AL, Steinman L, Wick W, Platten M. Lanz TV, et al. Among authors: opitz ca. Stem Cells Dev. 2010 May;19(5):657-68. doi: 10.1089/scd.2009.0385. Stem Cells Dev. 2010. PMID: 19886804 Free PMC article.

6

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.

Opitz CA, Litzenburger UM, Opitz U, Sahm F, Ochs K, Lutz C, Wick W, Platten M. Opitz CA, et al. Among authors: opitz u. PLoS One. 2011;6(5):e19823. doi: 10.1371/journal.pone.0019823. Epub 2011 May 20. PLoS One. 2011. PMID: 21625531 Free PMC article.

7

Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10.

Hertenstein A, Schumacher T, Litzenburger U, Opitz CA, Falk CS, Serafini T, Wick W, Platten M. Hertenstein A, et al. Among authors: opitz ca. Biochem Pharmacol. 2011 Sep 15;82(6):632-41. doi: 10.1016/j.bcp.2011.06.013. Epub 2011 Jun 14. Biochem Pharmacol. 2011. PMID: 21703247

8

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M. Opitz CA, et al. Nature. 2011 Oct 5;478(7368):197-203. doi: 10.1038/nature10491. Nature. 2011. PMID: 21976023 Free article.

9

The aryl hydrocarbon receptor as a promoter of malignant glioma.

Platten M, Opitz C, Wick W. Platten M, et al. Cell Cycle. 2012 Feb 15;11(4):643-4. doi: 10.4161/cc.11.4.19357. Cell Cycle. 2012. PMID: 22374665 No abstract available.

10

The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress.

Sahm F, Oezen I, Opitz CA, Radlwimmer B, von Deimling A, Ahrendt T, Adams S, Bode HB, Guillemin GJ, Wick W, Platten M. Sahm F, et al. Among authors: opitz ca. Cancer Res. 2013 Jun 1;73(11):3225-34. doi: 10.1158/0008-5472.CAN-12-3831. Epub 2013 Apr 2. Cancer Res. 2013. PMID: 23548271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters